London, United Kingdom · Founded 2015 · Privately Held (backing)
Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies. Turbine (Drug Discovery) is based in London, United Kingdom and was founded in 2015. Its last reported valuation was $90.2 million in Nov 2025. It has raised $64.4 million.
Last reported valuation
$90.2M
Oct 2026
Priced at
—
Total raised
$64.4M
Last round
—
Cap table — not yet on record
Turbine (Drug Discovery)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Turbine (Drug Discovery) with a free account
·The complete investor list: 24 names
·Watch Turbine (Drug Discovery): the Monday email on marks, rounds and moves
